AeroRx Therapeutics, a spin-off of US-based iPharma Lab's inhalation business and Taiwan-based startup HCmed Innova...
How do you describe Frontier’s relentless efforts in antiviral therapeutics? How have the market trends and pros...
Climate change - what once felt like a faraway threat has become an imminent crisis. The rise in the earth’s...
AstraZeneca’s Tezspire (tezepelumab) has been approved in Japan for the treatment of bronchial asthma in pati...
As part of their well-established partnership, the United Nations Institute for Training and Research (UNITAR) and Japan...
Johnson & Johnson (J&J) Consumer Health has announced the appointment of Raghu Krishnan as the new Area Managing...
US-based Legend Biotech Corporation has announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) ...
Eisai and nippon medac Co. have obtained manufacturing and marketing approval from the Japanese Ministry of Health, Labo...
Luye Pharma Group, with R&D centres in China, the US and Europe, has entered a distribution and marke...
French firm Inventiva and Chia Tai-Tianqing Pharmaceutical Group Co. (CTTQ), a subsidiary of China-based Sino Biopharm, ...
Japan-based Shionogi & Co., Shionogi Healthcare & Co. and Pixie Dust Technologies, Inc. (PxDT) have entered ...
It will address topics related to the manufacturing of sterile drug products and patient-friendly applications. This yea...
Australia's Medibio Limited has announced the appointment of Dr Thomas R. Young, M.D. as the company’s Chief Execu...
A. Menarini Asia-Pacific Holdings, part of The Menarini Group, and SciClone Pharmaceuticals (Holdings) have entered into...
China-based Everest Medicines, a biopharmaceutical company focused on developing and commercializing transformative phar...
A new targeted therapy to treat a rare bile duct cancer called cholangiocarcinoma has been approved for use in Aust...
US-based Peli BioThermal has announced its newest reusable, flexible temperature controlled shipping solution. CrÄ...
Neovii Pharmaceuticals, a Swiss based global specialty-care biopharmaceutical company, and Shanghai Fosun Pharmaceutical...
Zenas BioPharma, a global biopharmaceutical company having operations in the US & China, has announced the appointme...
Indian pharma major Lupin and DKSH, a leading partner for healthcare companies seeking to grow their business in Asia an...
AstraZeneca’s Forxiga (dapagliflozin), a sodium-glucose cotransporter 2 (SGLT2) inhibitor, has been approved in Ch...
Vernalis Research, a fully owned subsidiary of Chinese firm HitGen Inc., and US-based Unison Medicines Inc. have announc...
Swiss firm Helsinn Group and Singapore's Juniper Biologics Pte Ltd, a science-led healthcare company focused on research...
The Singapore Association of Pharmaceutical Industries (SAPI) announced that Ms Poh Hwee Tee (Country President, Singapo...
US-based BelleTorus Corporation and Singapore's ASLAN Pharmaceuticals have announced that ASLAN has licensed belleStudy ...
